Therapeutic Antibodies – News and Features

A consortium of scientists have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

Finalists for the New Product Award at the SLAS Europe conference showcase cutting-edge innovations in life sciences, evaluated on technical merit, commercial feasibility, originality, impact and market opportunity. Here, we take a look at the six nominees and the products competing for this year’s award.

In this article, we will explore the obstacles that reduce the efficacy of cell-based cancer immunotherapy and strategies to overcome them.

Researchers have used small membrane bubbles – which our cells use to communicate – to deliver targeted cancer treatments to tumors in mouse models, demonstrating reduced tumor growth and extended survival in one model.

Researchers have developed an approach to “deleting” a blood system affected by leukemia while simultaneously building up a new, healthy system with donor blood stem cells.

From AI's transformative role in drug discovery and CRISPR breakthroughs to the rise of biosimilars and real-world data. Learn how these innovations are reshaping pharma and driving progress in 2024.

Pairing a personalized dendritic cell vaccine with an immune-boosting compound improves the immune response to malignant gliomas.

In this article, we consider what neutrophils are, how they are generated, their function in the body and medical conditions related to them.

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety.

Michelle C. Werner discusses how tRNAs could transform the drug development paradigm from gene-centric to gene-agnostic and accelerate new therapies for 30 million or more patients whose genetically driven disease can be classified under Stop Codon Disease.